{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:42:40Z","timestamp":1767163360177,"version":"build-2238731810"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T00:00:00Z","timestamp":1271808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetic Medicine"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Diabet. Med. 27, 538\u2013543 (2010)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Aims\u2002<\/jats:bold>\n                      Silent cerebral infarction (SCI) is an independent risk factor for future symptomatic stroke. Although the prevalence of SCI is closely related to kidney function in non\u2010diabetic individuals, evidence is lacking whether albuminuria and\/or reduced estimated glomerular filtration rate (eGFR) independently increase the risk of SCI in diabetic patients. We therefore examined the relationships between albuminuria, eGFR and SCI in patients with Type\u20032 diabetes mellitus (T2DM).\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Methods\u2002<\/jats:bold>\n                      We studied 786 T2DM patients with an eGFR\u2003\u2265\u200315\u2003ml\/min 1.73\/m\n                      <jats:sup>2<\/jats:sup>\n                      , including 337 women and 449 men [mean (\u00b1\u2003\n                      <jats:sc>sd<\/jats:sc>\n                      ), age 65\u2003\u00b1\u200311\u2003years]. All patients underwent cranial magnetic resonance imaging (MRI) to detect SCI. GFR was estimated using the modified three\u2010variable equation for Japanese subjects. Albuminuria was defined as a first morning urinary albumin\u2010to\u2010creatinine ratio (ACR)\u2003\u2265\u200330\u2003mg\/g.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Results\u2002<\/jats:bold>\n                      SCI was detected in 415 (52.8%) of the subjects. The prevalence of SCI was significantly associated with both elevated ACR and decreased eGFR in univariate analysis. In multivariate logistic regression analysis, urinary ACR remained independently associated with SCI after adjusting for conventional cardiovascular risk factors [odds ratio (OR) of urinary ACR per logarithmical value: 1.89, 95% confidence interval (CI)\u2003=\u20031.41\u20132.51,\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.001]; however, eGFR was no longer significantly associated with SCI (OR per ml\/min 1.73\/m\n                      <jats:sup>2<\/jats:sup>\n                      \u2003=\u20030.99, 95% CI\u2003=\u20030.98\u20131.00,\n                      <jats:italic>P<\/jats:italic>\n                      \u2003=\u20030.095).\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Conclusion\u2002<\/jats:bold>\n                      In conclusion, albuminuria but not decreased eGFR may be an independent predictor of prevalent SCI in patients with T2DM.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-5491.2010.02922.x","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T03:51:37Z","timestamp":1271821897000},"page":"538-543","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Relationship between chronic kidney disease and silent cerebral infarction in patients with Type\u20032 diabetes"],"prefix":"10.1111","volume":"27","author":[{"given":"R.","family":"Bouchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Babazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Nyumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Toya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,21]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Kidney Disease Outcome Quality Initiative","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00397.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0248"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.30"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn356"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/hs0102.101629"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.1.73-a"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.10.1932"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00351.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022066"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.04.029"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn419"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000032241.58727.49"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000052631.98405.15"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic)","volume":"113","author":"Hirsch AT","year":"2006","journal-title":"Circulation"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-008-0406-6"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"e_1_2_7_21_2","first-page":"531","article-title":"Nephropathy in diabetes","volume":"322","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.11.2033"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diab.41.8.909","article-title":"Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria","volume":"41","author":"Collier A","year":"1992","journal-title":"Diabetes"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00768.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.137"},{"key":"e_1_2_7_27_2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diab.43.3.426","article-title":"PAI\u20101 and factor VII activity are higher in IDDM patients with microalbuminuria","volume":"43","author":"Gruden G","year":"1994","journal-title":"Diabetes"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70002-8"},{"key":"e_1_2_7_29_2","first-page":"658","article-title":"The relationship between albuminuria and hypercholesterolemia","volume":"17","author":"Shankar A","year":"2004","journal-title":"J Nephrol"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000168052.00426.65"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2008.27"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.493494"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.026"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005010006"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_2_7_36_2","first-page":"1158","article-title":"Cigarette smoking and other risk factors for silent cerebral infarction in the general population","volume":"28","author":"Howard G","year":"1998","journal-title":"Stroke"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.6.1158"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.9.1217"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.516575"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70170-9"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.7.1838"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-5491.2010.02922.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-5491.2010.02922.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-5491.2010.02922.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:37:44Z","timestamp":1698651464000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-5491.2010.02922.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,21]]},"references-count":40,"aliases":["10.1111\/j.1464-5491.2009.02922.x"],"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1464-5491.2010.02922.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-5491.2010.02922.x","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,21]]},"assertion":[{"value":"2010-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}